Kellner Capital’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-65,697
Closed -$3.61M 53
2022
Q2
$3.61M Buy
+65,697
New +$3.45M 2.44% 13

Other funds holding SRRA

Kellner Capital's SRRA Position: Q3 2022 in Review

Kellner Capital sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 65,697 shares — an estimated $3.61M sold.

Kellner Capital first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $3.61M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Kellner Capital reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Kellner Capital sold 65,697 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $3.61M.
  • Kellner Capital first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Kellner Capital's Sierra Oncology, Inc. Common Stock position peaked at $3.61M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Kellner Capital's 13F filing for Q3 2022, filed 14 Nov 2022.